The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Thermo Fisher Scientific inked a five-year distribution deal with British diagnostics maker Osmetech plc that will see the Waltham lab instruments manufacturer distribute some Osmetech products.
Fisher’s HealthCare division will sell Osmetech’s eSensor XT-8 instrument platform and molecular diagnostic tests and consumables in the United States.
Defective batteries and a software glitch in one of Zoll Medical Corp.‘s defibrillators may have killed two people, the Chelmsford device maker warned.
Zoll issued a “voluntary worldwide field corrective action” on its AED Plus automated external defibrillator after discovering the problem.
Stockholders of Orthofix International NV fought back a proxy challenge by a New York-based hedge fund.
The McKinney, Texas-based orthopedic device manufacturer said its shareholders beat back an attempt by Ramius LLC to oust four current board members and install their own people.
Orthofix also runs offices in Boston and a production facility in Springfield.
GE and Intel Corp. are in the healthcare business — big time.
The twin colossi will spend $250 million over five years to develop products to remotely monitor patients’ health. The growing field, called “telemedicine” or “e-health,” allows physicians to remotely evaluate, diagnose and treat patients outside of the doctor’s office.
News of the deal broke yesterday, but the companies made the official announcement at a press conference today in New York.
Intel Corp. and General Electric Co. are about to jump into the healthcare pool together, the Wall Street Journal reported.
A press conference is slated for April 2 in New York, hosted by Intel CEO Paul Otellini and GE CEO Jeffrey Immelt, where the two are expected to announce their collaboration.
Intel, the microprocessing giant, isn’t involved in healthcare but has been working for years to build a business in the sector.
Insulet Corp. took home the Best New Product award in the medical and science category at the 2009 Edison Awards for its OmniPod insulin pump.
The Google-sponsored awards are given to products that “excel in marketplace, innovation, marketplace success, technological innovation, market structure, innovation, and societal impact.” Past winners include Apple Computer, Johnson & Johnson and Chrysler.
Clinical Data Inc. agreed to sell its Cogenics division to Beckman Coulter Inc. for about $17 million.
The Newton-based genomics firm said the deal is part of its strategy to divest non-core businesses and focus on targeted therapeutics and biomarker development.
The Cogenics business provides outsourced genomics services. It will be integrated into Orange County, Calif.-based Beckman Coulter’s Agencourt Biosciences genomics services business.
Clinical Data will get about $15.4 million when the deal closes and get to keep roughly $2 million in cash from Cogenics just before the sale.
Inverness Medical Innovations Inc. added an ovarian cancer expert to its board of directors.
The Waltham-based diagnostics maker said it named Dr. Eli Adashi to its board and compensation committee.
People suffering from toenail fungus might be one step closer to a cure, thanks to Nomir Medical Technologies‘ new direct optical energy device.
The company’s Noveon system, which uses infrared technology to wipe out bacteria and fungal infections, showed in recent trials that 74 percent of the 32 subjects with onychomycosis, or toenails infected by fungus, had significantly less fungus after two treatments.
Older heart disease patients with drug-eluting stents fare better when it comes to heart attacks and mortality rates than patients with bare metal stents, according to a study funded by the federal Health & Human Services dept.’s Agency for Healthcare Research and Quality.
A study by Interleukin Genetics Inc. shows that women are more likely to suffer vertebral fractures and osteoporosis if they carry a specific gene variation.
The Waltham-based biomarker maker, which is flirting with a de-listing by the New York Stock Exchange, said its clinical study of 1,200 Asian women that Korean women are 70 percent more disposed to vertebral fracture if they carry a genetic variation in the IL-10 gene.
